[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Shimada et al., 2018 - Google Patents

T-cell-intrinsic receptor interacting protein 2 regulates pathogenic T helper 17 cell differentiation

Shimada et al., 2018

View HTML @Full View
Document ID
1139318914809058086
Author
Shimada K
Porritt R
Markman J
O’rourke J
Wakita D
Rivas M
Ogawa C
Kozhaya L
Martins G
Unutmaz D
Baloh R
Crother T
Chen S
Arditi M
Publication year
Publication venue
Immunity

External Links

Snippet

Summary Receptor interacting protein 2 (RIP2) plays a role in sensing intracellular pathogens, but its function in T cells is unclear. We show that RIP2 deficiency in CD4+ T cells resulted in chronic and severe interleukin-17A-mediated inflammation during …
Continue reading at www.cell.com (HTML) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology

Similar Documents

Publication Publication Date Title
Shimada et al. T-cell-intrinsic receptor interacting protein 2 regulates pathogenic T helper 17 cell differentiation
Malik et al. Transcription factor Foxo1 is essential for IL-9 induction in T helper cells
Wang et al. Iron drives T helper cell pathogenicity by promoting RNA-binding protein PCBP1-mediated proinflammatory cytokine production
Boonpiyathad et al. Der p 1‐specific regulatory T‐cell response during house dust mite allergen immunotherapy
Delgoffe et al. Stability and function of regulatory T cells is maintained by a neuropilin-1–semaphorin-4a axis
Lin et al. IL-1–induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation
O'Connell et al. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development
Mazzoni et al. Eomes controls the development of Th17‐derived (non‐classic) Th1 cells during chronic inflammation
Zhu et al. The transcription factor T-bet is induced by multiple pathways and prevents an endogenous Th2 cell program during Th1 cell responses
Wu et al. Ablation of transcription factor IRF4 promotes transplant acceptance by driving allogenic CD4+ T cell dysfunction
Ren et al. Foxp1 is critical for the maintenance of regulatory T-cell homeostasis and suppressive function
Chen et al. Control of Treg cell homeostasis and immune equilibrium by Lkb1 in dendritic cells
López et al. Th17 responses and natural IgM antibodies are related to gut microbiota composition in systemic lupus erythematosus patients
Schmitt et al. The cytokine TGF-β co-opts signaling via STAT3-STAT4 to promote the differentiation of human TFH cells
Sahoo et al. Batf is important for IL-4 expression in T follicular helper cells
Wolf et al. Autonomous TNF is critical for in vivo monocyte survival in steady state and inflammation
Collison et al. IL-35-mediated induction of a potent regulatory T cell population
Huang et al. IL-27 promotes the expansion of self-renewing CD8+ T cells in persistent viral infection
van der Veeken et al. Genetic tracing reveals transcription factor Foxp3-dependent and Foxp3-independent functionality of peripherally induced Treg cells
Ju et al. Modulation of STAT‐3 in rheumatoid synovial T cells suppresses Th17 differentiation and increases the proportion of Treg cells
Martinet et al. Type I interferons regulate eomesodermin expression and the development of unconventional memory CD8+ T cells
Xiao et al. The costimulatory receptor OX40 inhibits interleukin-17 expression through activation of repressive chromatin remodeling pathways
Yasuda et al. Satb1 regulates the effector program of encephalitogenic tissue Th17 cells in chronic inflammation
Yu et al. STAT3 Regulates Proliferation and Survival of CD8+ T Cells: Enhances Effector Responses to HSV‐1 Infection, and Inhibits IL‐10+ Regulatory CD8+ T Cells in Autoimmune Uveitis
Campos Carrascosa et al. Reciprocal regulation of the Il9 locus by counteracting activities of transcription factors IRF1 and IRF4